Albulushi Arif, Balushi Aisha Al, Shahzad Muhhamed, Bulushi Ismail Al, Lawati Hatim Al
Department of Adult Cardiology, National Heart Center, The Royal Hospital, Muscat, Oman.
National Hyperbaric Medicine Centre, The Royal Hospital, Muscat, Oman.
Cardiooncology. 2024 Jun 15;10(1):36. doi: 10.1186/s40959-024-00240-2.
The landscape of cancer survivorship is increasingly populated by individuals facing a spectrum of cardiometabolic risks, attributed to both their oncological history and treatment regimens. This manuscript synthesizes findings from various studies, highlighting the prevalence of traditional risk factors-hypertension, dyslipidemia, diabetes-as well as emergent concerns like obesity and metabolic syndrome among survivors. The impact of demographic variables, specific cancer types, and treatment modalities on cardiometabolic health is explored. Through a lens of multidisciplinary management and future research directives, we advocate for an integrative approach to cardiometabolic health in cancer survivors, aiming to ensure their victory over cancer extends into long-term well-being.
癌症幸存者群体中，越来越多的人面临一系列心脏代谢风险，这归因于他们的肿瘤病史和治疗方案。本手稿综合了各项研究的结果，强调了传统风险因素（高血压、血脂异常、糖尿病）的普遍性，以及幸存者中肥胖和代谢综合征等新出现的问题。探讨了人口统计学变量、特定癌症类型和治疗方式对心脏代谢健康的影响。通过多学科管理和未来研究方向的视角，我们倡导对癌症幸存者的心脏代谢健康采取综合方法，旨在确保他们战胜癌症后能实现长期健康。
